BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 195028)

  • 1. Increased purine nucleotides in adenosine deaminase-deficient lymphocytes.
    Schmalstieg FC; Nelson JA; Mills GC; Monahan TM; Goldman AS; Goldblum RM
    J Pediatr; 1977 Jul; 91(1):48-51. PubMed ID: 195028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine metabolism in adenosine deaminase deficiency.
    Mills GC; Schmalstieg FC; Trimmer KB; Goldman AS; Goldblum RM
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2867-71. PubMed ID: 1066699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purine dysfunction in cells from patients with adenosine deaminase deficiency.
    Benke PJ; Dittmar D
    Pediatr Res; 1976 Jul; 10(7):642-6. PubMed ID: 132630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purine metabolism in adenosine deaminase deficiency.
    Simmonds HA; Sahota A; Potter CF; Perrett D; Hugh-Jones K; Watson JG
    Ciba Found Symp; 1978; (68):255-62. PubMed ID: 387357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.
    Agarwal RP; Crabtree GW; Parks RE; Nelson JA; Keightley R; Parkman R; Rosen FS; Stern RC; Polmar SH
    J Clin Invest; 1976 Apr; 57(4):1025-35. PubMed ID: 947948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenine and adenosine metabolism in lymphocytes deficient in adenosine deaminase (ADA) activity.
    Raivio KO; Schwartz AL; Stern RC; Polmar SH
    Adv Exp Med Biol; 1977; 76A():456-62. PubMed ID: 855721
    [No Abstract]   [Full Text] [Related]  

  • 7. Adenosine deaminase deficiency and severe combined immunodeficiency disease.
    Thompson LF; Seegmiller JE
    Adv Enzymol Relat Areas Mol Biol; 1980; 51():167-210. PubMed ID: 6255772
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immune insufficiency in enzyme defects of purine metabolism].
    Müller G
    Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of adenosine receptor on human lymphocytes in vitro and its possible role in the adenosine deaminase-deficient form of severe combined immunodeficiency.
    Schwartz AL; Stern RC; Polmar SH
    Clin Immunol Immunopathol; 1978 Apr; 9(4):499-505. PubMed ID: 206401
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological and metabolic reconstitution following successful bone marrow transplantation from a HLA-identical sibling in an infant with adenosine deaminase deficiency and severe combined immunodeficiency: partial restoration of purine metabolism.
    Hyodo Y; Itoh R; Kurozumi H; Ibe M; Oka J; Yamada K
    Adv Exp Med Biol; 1989; 253A():543-7. PubMed ID: 2624235
    [No Abstract]   [Full Text] [Related]  

  • 11. Adenosine deaminase deficiency without immunodeficiency: clinical and metabolic studies.
    Borkowsky W; Gershon AA; Shenkman L; Hirschhorn R
    Pediatr Res; 1980 Jul; 14(7):885-9. PubMed ID: 6251420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase.
    Cohen A; Gudas LJ; Ullman B; Martin DW
    Ciba Found Symp; 1978; (68):101-14. PubMed ID: 115659
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal platelet aggregation in severe combined immunodeficiency disease with adenosine deaminase deficiency.
    Schwartz AL; Polmar SH; Stern RC; Cowan DH
    Br J Haematol; 1978 Jun; 39(2):189-94. PubMed ID: 678472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T; Gruchalska E
    Acta Haematol Pol; 1979; 10(3):205-10. PubMed ID: 116467
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlations between purine levels, clinical and immunological status in ADA deficiency.
    Simmonds HA; Fairbanks LD; Morris GS; Hugh-Jones K; Morgan G; Levinsky RJ
    Adv Exp Med Biol; 1986; 195 Pt A():93-9. PubMed ID: 3728190
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical and functional abnormalities in lymphocytes from an adenosine deaminase-deficient patient during enzyme replacement therapy.
    Hutton JJ; Wiginton DA; Coleman MS; Fuller SA; Limouze S; Lampkin BC
    J Clin Invest; 1981 Aug; 68(2):413-21. PubMed ID: 7263861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.
    Donofrio J; Coleman MS; Hutton JJ; Daoud A; Lampkin B; Dyminski J
    J Clin Invest; 1978 Oct; 62(4):884-7. PubMed ID: 308954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
    Ullman B; Cohen A; Martin DW
    Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency.
    Morgan G; Levinsky RJ; Hugh-Jones K; Fairbanks LD; Morris GS; Simmonds HA
    Clin Exp Immunol; 1987 Dec; 70(3):491-9. PubMed ID: 3436096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine- and deoxyadenosine-mediated altered pyrimidine metabolism in human adeosine deaminase-deficient lymphoblasts.
    Parker NF; Jack I; Van Der Weyden MB
    J Lab Clin Med; 1982 May; 99(5):731-9. PubMed ID: 6175708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.